HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.
about
HPV Carcinomas in Immunocompromised PatientsHIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and TreatmentHIV infection, aging, and immune function: implications for cancer risk and preventionHuman papillomavirus and gastrointestinal cancer: A reviewKnowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in KenyaEpidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers.Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapyAtypical squamous cells, cannot exclude high grade squamous intraepithelial (ASC-H) in HIV-positive women.Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods.Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.Incidence and progression of cervical lesions in women with HIV: a systematic global review.Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, ZambiaResidual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study.Validation of cervical cancer screening methods in HIV positive women from Johannesburg South AfricaFrequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancerRapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African womenCervical cancer risk factors among HIV-infected Nigerian womenReview of HIV-Related Cytopathology.The impact of HAART on HPV-related cervical disease.The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional studyInternational scientific collaboration in HIV and HPV: a network analysis.Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review.Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysisHuman papillomavirus vaccination: current indications and future directionsOutcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women.IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDSCost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia.The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia
P2860
Q26799629-E1870A01-EE58-4A43-B691-641657D4A095Q26991563-A9EF396F-E37D-462B-B204-A9DDB1D3E222Q27004165-C644CFF1-12F9-42B0-A527-C006FB24E2B5Q28069930-F7FA8F9F-A064-4C10-898C-85555E142A97Q28727315-F255ABA5-7C58-4D74-B854-B7D36812D540Q30244304-BFA06EB6-2C52-4701-AE47-8A70C3C00825Q33526682-39BD00D7-6A93-43FC-B313-306721F47D63Q33555812-D66ADA0D-6C63-48D1-BAC2-C35343FB2FD6Q33626438-7508005D-7131-47E4-B3B2-FB2BFE5480FBQ33638545-C93401A5-A9FC-4D33-BDC3-3B02D26B90DEQ33716047-2B3EDB57-D600-4529-9F79-303088FE02AFQ33718690-F225C1DD-C17F-4F78-BE55-BAA3574FA5EDQ33762765-147FA5B6-3A5A-4366-8CE9-E5C1F4189D04Q33787551-05464C23-D140-4B0D-9AED-9A0C811C8A0EQ33825703-35EB3520-123B-404C-8243-FEF26FDF4806Q33859622-5AD9BE69-91A1-4426-9FED-43FBCB019CEEQ33869309-F447E754-41C7-47D2-B450-EF23D64FEEF3Q33924965-5B6B628E-9043-406A-B3AA-CE6A78284A7BQ33988391-1D311FD6-95EE-4CAB-8C48-847ECEB145B1Q34173391-729BCB96-D141-4BB4-9684-7C91F11290E3Q34400805-69A6C879-A953-4B2A-834D-7C857D7540BAQ34459424-5669B303-C060-43EE-BA87-D2BEE60D417DQ34551436-5A43C2EA-01EB-4CA8-8714-DB196E0B6F7AQ34576482-C4EE507C-3B47-458D-8388-53FC6063C288Q34595508-B345743C-8825-4D0D-97E5-8BF0B5235E62Q34764388-8C24F538-A61C-4AAC-9F04-8A9771A303C6Q34773250-F7B326C9-F9ED-45CA-AD67-DF40A876FF72Q34954078-7A897BD9-87C8-40FE-BB58-4B5879FC1434Q35025062-D463D8D9-4810-4667-87A0-4C8CF1CFC9F4Q35078412-62D15D88-13C0-47B7-9BAE-FBF43BC99E1AQ35135108-4F5F39B5-6A28-4109-B5B8-CDDD5D991F6BQ35185950-33C4A50B-3249-423C-8D1F-04583EAA96BFQ35188247-0494A261-FDB9-431A-8F2D-C248F5205F8EQ35413976-B8B788B8-8FE9-4F5F-8C7F-0094F42FF287Q35558593-AEA6336F-BFE4-486B-BBC2-8B4E55C94156Q35655621-B139323B-A656-4738-9CB8-EE4D9797B481Q35784621-F5BD49F4-961C-43C1-9E48-402C0D387D70Q35865134-32A21EC1-F7BF-40CC-84BA-0381FCAF1AB8Q35894798-A01360E2-73E2-4BE5-9EB3-938D88310524Q36094880-3ADF0421-B7AB-4A62-A42E-B8AA74D21D4A
P2860
HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@en
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@nl
type
label
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@en
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@nl
prefLabel
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@en
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@nl
P2093
P1476
HIV, human papillomavirus, and ...... active antiretroviral therapy.
@en
P2093
Flavia Lillo
Hugo De Vuyst
Jennifer S Smith
P304
P356
10.1097/CEJ.0B013E3282F75EA1
P407
P577
2008-11-01T00:00:00Z